Signaling pathways
-
BA4810 JHDM-IN-1Summary: JHDM-IN-1 is an inhibitor of HDMs containing the JumonjiC structural domain. - BA4811 NUCC-0226272Summary: NUCC-0226272 is an effective targeted degradation of.
-
BA4812 EED226Summary: EED226, a multi-comb inhibitor of complex 2, binds to the K27me3 pocket on embryonic ectodermal development (EED) and exhibits potent antitumor activity in a transplanted tumor mouse model. - BA4813 MRTX-1719Summary: MRTX-1719 is a potent, orally active, selective complex inhibitor.
- BA4814 TP-064Summary: TP-064 is a potent and selective protein arginine methyltransferase 4 inhibitor (<10nM).
- BA4815 LLY-283Summary: LLY-283 is a potent, selective, orally available protein arginine methyltransferase 5 inhibitor.
- BA4817 SGC3027Summary: SGC3027 is a histone methyltransferase inhibitor.
- BA4818 TNG908Summary: TNG908 is a synergistic inhibitor of MTAP.
- BA4819 EPZ-719Summary: EPZ-719 is a selective and orally potent inhibitor of M.
- BA4820 MS67Summary: MS67 is an effective and selective WD40 repeat domain protein 5 degrader.